Private-equity and corporate finance-focused investor and operator with experience across industrials and specialty manufacturing sectors. Cody Gehman is experienced in originating middle-market investments, leading diligence and driving portfolio-company operational improvements, with prior roles spanning investment teams and operating management. Market-relevant strengths include deal sourcing, financial modeling, carve-out execution and board-level oversight. Tailored to institutional allocators, family offices and strategic acquirers seeking operationally-driven growth investments.
Private-equity and corporate finance-focused investor and operator with experience across industrials and specialty manufacturing sectors. Cody Gehman is experienced in originating middle-market investments, leading diligence and driving portfolio-company operational improvements, with prior roles spanning investment teams and operating management. Market-relevant strengths include deal sourcing, financial modeling, carve-out execution and board-level oversight. Tailored to institutional allocators, family offices and strategic acquirers seeking operationally-driven growth investments.
Focuses on operationally-led private equity in middle-market industrials and specialty manufacturing, prioritizing carve-outs and control or influential minority positions where operational improvements drive value. Utilizes sector expertise to source proprietary deals, underwrite through detailed financial modeling and execute rigorous diligence. Capital allocation favors disciplined, growth-with-margin expansion strategies, paired with hands-on portfolio management, KPI-driven turnarounds and three-to-seven year value realization horizons. Risk controlled via conservative leverage, contingency planning and board-level governance.
Focuses on operationally-led private equity in middle-market industrials and specialty manufacturing, prioritizing carve-outs and control or influential minority positions where operational improvements drive value. Utilizes sector expertise to source proprietary deals, underwrite through detailed financial modeling and execute rigorous diligence. Capital allocation favors disciplined, growth-with-margin expansion strategies, paired with hands-on portfolio management, KPI-driven turnarounds and three-to-seven year value realization horizons. Risk controlled via conservative leverage, contingency planning and board-level governance.
| Trades 2618 | Longs Won 1481/2618 56% | Profit Factor 5.41 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $527,680.14 |
| Average Win $151,294.6 | Best Trade (Aug 20) $13.45M | Sharpe Ratio -134.46 |
| Average Loss -$36,460.4 | Worst Trade (Jun 29) -$3.4M | Z-Score 1.44 (84.9%) |
| Commissions $0 | Avg. Trade Length 7m 3w 4d | Expectancy $69,752.41 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 35,714 | 32,143 | 28,571 | 25,000 | 21,429 | 17,857 | 14,286 | 10,714 | 7,143 | 3,571 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 134,402 | $33.63M | $41.52M | - | $7.89M | 23.45% | -7.354% |
ABBV AbbVie Inc. | 2,100 | $398,709.99 | $526,974 | - | $128,264.01 | 32.17% | -2.513% |
ABT Abbott Laboratories | 49,984 | $5.41M | $5.28M | - | -$125,848.95 | -2.33% | +0.085% |
ACWI iShares MSCI ACWI ETF | 2,436 | $295,380.96 | $381,063.46 | - | $85,682.5 | 29.01% | +0.495% |
ADI Analog Devices, Inc. | 20,936 | $4.47M | $7.69M | - | $3.22M | 71.93% | +0.202% |
AEM Agnico Eagle Mines Limited | 1,533 | $301,597.96 | $222,698.91 | - | -$78,899.05 | -26.16% | -3.635% |
AFL Aflac Inc. | 58,400 | $6.08M | $7.44M | - | $1.37M | 22.5% | +0.094% |
AIQ Global X Artificial Intelligence & Technology ETF | 5,742 | $301,317.95 | $338,146.38 | - | $36,828.43 | 12.22% | +0.341% |
AMAT Applied Materials, Inc. | 1,003 | $350,821 | $509,193.02 | - | $158,372.02 | 45.14% | +1.176% |
AMD Advanced Micro Devices, Inc. | 876 | $178,204.64 | $417,107.39 | - | $238,902.75 | 134.06% | -1.904% |
AMGN Amgen Inc. | 15,561 | $4.25M | $5.99M | - | $1.74M | 40.89% | -0.64% |
AMRX Amneal Pharmaceuticals Inc. | 36,054 | $285,548 | $660,509.28 | - | $374,961.28 | 131.31% | -0.973% |
AMT American Tower Corporation | 15,889 | $2.97M | $2.75M | - | -$216,146.09 | -7.28% | -0.631% |
AMZN Amazon.com Inc | 11,336 | $2.48M | $3.08M | - | $594,358.55 | 23.92% | +15.321% |
AOA iShares Core Aggressive Allocation ETF | 10,714 | $833,495.6 | $1.04M | - | $203,083.9 | 24.37% | +0.301% |
AOR iShares Core 60/40 Balanced Allocation ETF | 9,950 | $577,085.91 | $681,873.5 | - | $104,787.59 | 18.16% | +0.058% |
APD Air Products and Chemicals, Inc. | 16,698 | $4.8M | $4.92M | - | $125,165.33 | 2.61% | -1.769% |
ASML ASML Holding N.V. New York Registry Shares | 129 | $256,638 | $210,141 | - | -$46,497 | -18.12% | -1.359% |
AVDV Avantis International Small Cap Value ETF | 4,483 | $432,060.14 | $469,101.12 | - | $37,040.98 | 8.57% | -0.476% |
AVGO Broadcom Inc. | 2,202 | $648,627.23 | $857,194.56 | - | $208,567.33 | 32.16% | +0.371% |